Completed PHASE3 INTERVENTIONAL 2-arm NCT00299039

T3AI-Pain After Breast Surgery (T3AI)

A Randomized Controlled Trial Comparing Combination Therapy of Acetaminophen Plus Ibuprofen Versus Tylenol #3® for the Treatment of Pain After Breast Surgery.

Sponsor: Nova Scotia Health Authority

Conditions Breast Diseases Pain

Interventions acetaminophen plus codeine acetaminophen plus ibuprofen

Updated 5 times since 2017 Last updated: Jan 30, 2009 Started: May 31, 2006 Primary completion: Jun 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00299039, this PHASE3 trial focuses on Breast Diseases and Pain and remains completed. Sponsored by Nova Scotia Health Authority, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nova Scotia Health Authority

Data source: Nova Scotia Health Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halifax, Canada